Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Takes Relaxed Stance On DTC Ads For Products With “Black Box”

Executive Summary

FDA is not requiring the inclusion of the full text of a "black box" warning in new direct-to-consumer advertisements for antidepressants

You may also be interested in...



Reminder Ads Stay Healthy In Canada Even As They Are Frozen Out Of The U.S.

Pharmaceutical companies continue to run television "reminder" ads for their products in Canada even as they have pledged to stop the practice in the United States

Reminder Ads Stay Healthy In Canada Even As They Are Frozen Out Of The U.S.

Pharmaceutical companies continue to run television "reminder" ads for their products in Canada even as they have pledged to stop the practice in the United States

Disease Awareness Ads Increase, Along With Firms’ Need For Clarity From FDA

Industry would like greater clarification from FDA on appropriate disease awareness advertising when the agency finalizes its draft guidance

Related Content

Topics

UsernamePublicRestriction

Register

LL1134531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel